Suppr超能文献

使用 Oxford Nanopore Technologies' MinION 设备对质粒 DNA 进行完整序列验证。

Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies' MinION device.

机构信息

Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, 675 W 10th Ave, Vancouver, BC, V5Z 1L3, Canada.

Department of Molecular Biology and Biochemistry, Simon Fraser University, SSB8166 - 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.

出版信息

BMC Bioinformatics. 2023 Mar 24;24(1):116. doi: 10.1186/s12859-023-05226-y.

Abstract

BACKGROUND

Sequence verification is essential for plasmids used as critical reagents or therapeutic products. Typically, high-quality plasmid sequence is achieved through capillary-based Sanger sequencing, requiring customized sets of primers for each plasmid. This process can become expensive, particularly for applications where the validated sequence needs to be produced within a regulated and quality-controlled environment for downstream clinical research applications.

RESULTS

Here, we describe a cost-effective and accurate plasmid sequencing and consensus generation procedure using the Oxford Nanopore Technologies' MinION device as an alternative to capillary-based plasmid sequencing options. This procedure can verify the identity of a pure population of plasmid, either confirming it matches the known and expected sequence, or identifying mutations present in the plasmid if any exist. We use a full MinION flow cell per plasmid, maximizing available data and allowing for stringent quality filters. Pseudopairing reads for consensus base calling reduces read error rates from 5.3 to 0.53%, and our pileup consensus approach provides per-base counts and confidence scores, allowing for interpretation of the certainty of the resulting consensus sequences. For pure plasmid samples, we demonstrate 100% accuracy in the resulting consensus sequence, and the sensitivity to detect small mutations such as insertions, deletions, and single nucleotide variants. In test cases where the sequenced pool of plasmids contains subclonal templates, detection sensitivity is similar to that of traditional capillary sequencing.

CONCLUSIONS

Our pipeline can provide significant cost savings compared to outsourcing clinical-grade sequencing of plasmids, making generation of high-quality plasmid sequence for clinical sequence verification more accessible. While other long-read-based methods offer higher-throughput and less cost, our pipeline produces complete and accurate sequence verification for cases where absolute sequence accuracy is required.

摘要

背景

序列验证对于用作关键试剂或治疗产品的质粒至关重要。通常,高质量的质粒序列是通过毛细管 Sanger 测序实现的,需要为每个质粒定制一组引物。这个过程可能会变得昂贵,特别是对于需要在受监管和质量控制的环境中生成经验证的序列的应用,以便进行下游临床研究应用。

结果

在这里,我们描述了一种使用 Oxford Nanopore Technologies' MinION 设备进行经济高效且准确的质粒测序和共识生成的程序,作为毛细管质粒测序方法的替代方案。该程序可以验证纯质粒群体的身份,无论是确认其与已知和预期的序列匹配,还是确定质粒中存在的突变(如果存在)。我们为每个质粒使用一个完整的 MinION 流池,最大限度地利用可用数据,并允许严格的质量过滤。用于共识碱基调用的伪配对读取将读取错误率从 5.3%降低到 0.53%,并且我们的堆积共识方法提供了每个碱基的计数和置信度得分,允许解释生成的共识序列的确定性。对于纯质粒样本,我们证明了所得共识序列的 100%准确性,并且对插入、缺失和单核苷酸变体等小突变的检测灵敏度。在测序的质粒池包含亚克隆模板的测试案例中,检测灵敏度与传统毛细管测序相似。

结论

与将质粒的临床级测序外包相比,我们的流水线可以节省大量成本,使临床序列验证的高质量质粒序列生成更容易获得。虽然其他基于长读长的方法提供了更高的通量和更低的成本,但我们的流水线在需要绝对序列准确性的情况下可生成完整和准确的序列验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a59b/10039527/5b56fa87c13c/12859_2023_5226_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验